Laboratorios Farmaceuticos Rovi (ROVI)

Index:

IBEX 35

  49.04
   
  • 52 Week High:  91.50
  • 52 Week Low:  42.40
  • Currency: Euro
  • Shares Issued: 54.02m
  • Market Cap:  2,648.94m
  • RiskGrade: 165
  • Beta: 0.30

Fundamentals - based on IFRS

    (Millions)   (Millions)   (Millions)   (Millions)   (Millions)
Income Statement 31-Dec-23 31-Dec-22 31-Dec-21 31-Dec-20 31-Dec-19
Continuing Operations          
Revenue 829.51 817.70 648.68 459.42 382.46
Operating Profit/(Loss) 220.25 255.85 181.39 45.25 237.65
Profit Before Tax 220.41 257.97 182.63 75.22 41.88
Profit After Tax 170.30 199.66 153.08 71.14 39.27
           
Earnings per Share - Basic 320.00¢ 373.00¢ 276.00¢ 110.00¢ 70.00¢
Earnings per Share - Adjusted 320.00¢ 373.00¢ 276.00¢ 110.00¢ 70.00¢
           
Dividend per Share 129.38¢ 95.56¢ 38.12¢ 17.51¢ 7.98¢
    (Millions)   (Millions)   (Millions)   (Millions)   (Millions)
Balance Sheet 31-Dec-23 31-Dec-22 31-Dec-21 31-Dec-20 31-Dec-19
Assets          
Non-Current Assets          
Property, Plant & Equipment 253.65 215.54 181.77 52.13 131.61
Intangible Assets 33.90 35.74 38.56 37.49 45.08
Other Non-Current Assets 3.00 4.34 5.98 51.88 16.64
  290.55 255.63 226.31 141.50 193.33
Current Assets          
Inventories 337.97 311.94 245.47 74.68 158.81
Cash at Bank & in Hand 25.32 124.94 99.04 34.14 67.43
Other Current Assets 146.04 186.18 161.85 305.21 91.65
  509.33 623.07 506.36 414.03 317.89
           
Other Assets n/a n/a n/a n/a n/a
Total Assets 799.88 878.70 732.68 555.53 511.21
Current Liabilities          
Borrowings 13.19 12.73 6.42 0.17 12.70
Other Current Liabilities 186.66 281.16 183.97 160.53 94.01
           
Current Liabilities 199.84 293.89 190.39 160.71 106.71
           
Net Current Assets c309.49 c329.19 c315.97 c253.32 c211.18
           
Borrowings 52.24 59.44 66.75 44.83 72.10
Other Non-Current Liabilities 4.30 4.00 4.57 19.31 10.01
Non-Current Liabilities 56.55 63.44 71.31 64.14 82.12
           
Other Liabilities n/a n/a n/a n/a n/a
Total Liabilities 256.39 357.32 261.70 224.84 188.82
           
Net Assets 543.49 521.38 470.98 330.69 322.39
           
Shareholders Funds 539.39 520.01 470.98 330.69 322.39
           
Minority Interests/Other Equity 4.11 1.37 n/a n/a n/a
Total Equity 543.49 521.38 470.98 330.69 322.39
Cash Flow 31-Dec-23 31-Dec-22 31-Dec-21 31-Dec-20 31-Dec-19
Net Cash Flow From Operating Activities 113.25 237.60 149.44 13.90 (9.04)
Net Cash Flow from Investing Activities (52.03) (57.15) (40.84) 10.26 (40.47)
Net Cash Flow from Financing Activities (160.84) (154.54) (62.73) (20.82) 21.43
Net Increase/Decrease In Cash (99.62) 25.91 45.87 3.35 (28.08)
Ratios - based on IFRS 31-Dec-23 31-Dec-22 31-Dec-21 31-Dec-20 31-Dec-19
Continuing Operations          
PE Ratio - Adjusted 18.8 9.7 26.7 n/a 34.9
PEG - Adjusted n/a 0.3 0.2 n/a n/a
Earnings per Share Growth - Adjusted -14% 35% 151% 57% n/a
Dividend Cover 2.47 3.90 7.24 6.28 8.77
Revenue per Share 1,535.67¢ 1,513.81¢ 12.12¢ 850.53¢ 708.06¢
Pre-Tax Profit per Share 408.04¢ 477.57¢ 3.41¢ 139.25¢ 77.53¢
Operating Margin 26.55% 31.29% 27.96% 9.85% 62.14%
Return on Capital Employed 38.33% 46.25% 0.36% 22.24% 11.57%
           
Dividend Yield 2.1% 2.7% 0.5% 0.0% 0.3%
Dividend per Share Growth 35.39% 150.68% 117.70% 119.42% n/a
Operating Cash Flow per Share 209.66¢ 439.87¢ 276.66¢ 25.74¢ n/a
Cash Incr/Decr per Share (184.43¢) 47.97¢ 0.86¢ 6.20¢ (51.99¢)
Net Asset Value per Share (exc. Intangibles) 943.41¢ 899.06¢ 800.54¢ 542.80¢ 513.38¢
Net Gearing 7.44% -10.15% -5.49% 3.28% 5.39%

Key

* GAAP

a. Includes discontinued activities

b. Including assets due in more than one year

c. Not disclosed under IFRS

d. Total fixed assets

e. Includes borrowings

f. Included in cash flow from operating activities under IFRS

g. Included in net cash from investing activities under IFRS

h. Pre-tax

i. Capital expenditure

j. Based on operating cash flow before tax

k. Issue of ordinary shares

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are end of day values only.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Forecast figures based on normalised accounts.

 

Top of Page